Events & Presentations
Date | Event Details | Remind Me |
---|---|---|
Feb 4, 2021 4:30 PM EST
|
Arrowhead Pharmaceuticals 2021 First Quarter Results
|
Date | Event Details |
---|---|
May 23, 2019 8:30 AM PDT
|
20ᵀᴴ Annual B. Riley FBR Institutional Investor Conference
Beverly Hills
Christopher Anzalone, Ph.D., Arrowhead’s president and chief executive officer, will participate in a fireside chat presentation with Mayank Mamtani, B. Riley FBR research analyst
|
May 18, 2019 11:25 AM EDT
|
2019 National Lipid Association Scientific Sessions
View Presentation 948.9 KB
Aventura, FL
So Wong, Ph.D., Arrowhead’s director of biology, will deliver a poster presentation titled, “Personalized Medicine for Dyslipidemias by RNA Interference-Mediated Reductions in Apolipoprotein C3 or Angiopoietin-Like Protein 3” |
May 15, 2019 8:40 AM PDT
|
Bank of America Merrill Lynch 2019 Health Care Conference
Las Vegas, Nevada
Christopher Anzalone, Ph.D., Arrowhead’s president and chief executive officer, will deliver a corporate presentation
|
May 15, 2019 11:00 AM EDT
|
Vascular Discovery: From Genes to Medicine 2019 Scientific Sessions (ATVB|PVD)
View Presentation 3 MB
Boston
So Wong, Ph.D., Arrowhead’s director of biology, will deliver a poster presentation titled, “Reduction in Angiopoietin-Like Protein 3 via RNA Interference Improves Dyslipidemias and Hepatic Steatosis” |
May 8, 2019 4:30 PM EDT
|
Arrowhead Pharmaceuticals 2019 Second Quarter Results
|
Apr 10, 2019
|
The EASL International Liver Congress 2019
View Presentation 3.8 MB
View Presentation 3.5 MB
Oral Presentation:
Poster Presentation:
|
Apr 3, 2019 8:00 AM EDT
|
AACR Annual Meeting 2019
View Presentation 10.8 MB
So Wong, Ph.D., Arrowhead’s director of oncology, will deliver a poster presentation titled, “Optimizing the potency and dosing design for ARO-HIF2: An RNAi therapeutic for clear cell renal cell carcinoma”
|
Mar 27 - Mar 30, 2019
|
CSHL Meeting: RNA & Oligonucleotide Therapeutics
View Presentation 11.5 MB
Cold Spring Harbor, NY
Dr. Hamilton will deliver an oral presentation titled, “Cardiovascular and lipid disorders - A next frontier for TRiMTM RNAi”
|
Mar 26, 2019 4:35 PM EDT
|
Oligonucleotide & Precision Therapeutics (OPT) Congress
View Presentation 11.5 MB
Cambridge, MA
James Hamilton, M.D., Arrowhead’s vice president of clinical development, will deliver an oral presentation titled, “siRNA Clinical Development Based on the TRiMTM Platform”
|
Mar 18, 2019 9:30 AM EDT
|
Jefferies HBV Investor Summit
New York
Dr. Given will participate in a fireside chat presentation with Maury Raycroft, Ph.D., Jefferies Biotech Analyst
|